Séverine Sarp
-
- Breast Cancer Treatment Studies 4
-
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
- CAR-T cell therapy research 2
-
- Pituitary Gland Disorders and Treatments 2
-
- Biomedical Ethics and Regulation 4
-
- Advanced Breast Cancer Therapies 2
-
- Healthcare cost, quality, practices 2
- Co-authors
- Sérgio D. SimonChristine BouchardyGeorges VlastosFredrik TibergJohn G. RobertsHyma SchubertMargareta LindenElisabetta Rapiti
- Cited by
- Cancer ResearchOncologyToxicology
- Journals
- Journal of Clinical Oncology (4 papers)British Journal of Cancer (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Séverine Sarp
16 papers receiving 386 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 109
- Oncology 196
- Toxicology 18
- Endocrinology, Diabetes and Metabolism 47
- Pharmaceutical Science 15
Countries citing papers authored by Séverine Sarp
This map shows the geographic impact of Séverine Sarp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Sarp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Sarp more than expected).
Fields of papers citing papers by Séverine Sarp
This network shows the impact of papers produced by Séverine Sarp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Sarp. The network helps show where Séverine Sarp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Séverine Sarp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 0 | |
| 6 | 2020 | 82 | |
| 7 | 2020 | 8 | |
| 8 | 2018 | 13 | |
| 9 | 2018 | 4 | |
| 10 | 2017 | 106 | |
| 11 | 2017 | 6 | |
| 12 | 2017 | 6 | |
| 13 | 2017 | 6 | |
| 14 | Copy number aberration analysis to predict response to neoadjuvant anti-HER2 therapy: Results from the NeoALTTO phase III trial | 2017 | 0 |
| 15 | 2015 | 57 | |
| 16 | 2011 | 22 | |
| 17 | 2006 | 43 | |
| 18 | 2005 | 24 |
About Séverine Sarp
Séverine Sarp is a scholar working on Toxicology, Cancer Research, Oncology, Critical Care and Intensive Care Medicine and Hematology, having authored 18 papers that have together received 398 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Biomedical Ethics and Regulation (4 papers), Breast Cancer Treatment Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Advanced Breast Cancer Therapies (2 papers), CAR-T cell therapy research (2 papers), Healthcare cost, quality, practices (2 papers) and Pituitary Gland Disorders and Treatments (2 papers). The work is most often cited by research in Cancer Research (109 citations), Oncology (196 citations), Toxicology (18 citations), Endocrinology, Diabetes and Metabolism (47 citations) and Pharmaceutical Science (15 citations). Séverine Sarp has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Sérgio D. Simon, Christine Bouchardy, Georges Vlastos, Fredrik Tiberg, John G. Roberts, Hyma Schubert, Margareta Linden, Elisabetta Rapiti, G Fioretta and Camilla Cervin. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Bone Marrow Transplantation, European Journal Of Haematology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.